Sunzen Biotech Bhd

XKLS:0148 (Malaysia)  
RM 0.31 (-1.61%) Apr 22
50.84
P/B:
1.71
Market Cap:
RM 215.12M ($ 45.01M)
Enterprise V:
RM 198.21M ($ 41.48M)
Volume:
956.50K
Avg Vol (2M):
2.72M
Volume:
956.50K
Avg Vol (2M):
2.72M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sunzen Biotech Bhd ( ) from 2008 to Apr 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sunzen Biotech Bhd stock (XKLS:0148) PE ratio as of Apr 23 2024 is 50.84. More Details

Sunzen Biotech Bhd (XKLS:0148) PE Ratio (TTM) Chart

To

Sunzen Biotech Bhd (XKLS:0148) PE Ratio (TTM) Historical Data

Total 1240
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Sunzen Biotech Bhd PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-23 50.8 2024-02-15 46.7
2024-04-22 50.8 2024-02-14 46.7
2024-04-19 51.7 2024-02-13 46.7
2024-04-18 54.2 2024-02-12 45.8
2024-04-17 54.2 2024-02-09 45.8
2024-04-16 55.0 2024-02-08 46.7
2024-04-15 56.7 2024-02-07 47.5
2024-04-12 56.7 2024-02-06 47.5
2024-04-09 56.7 2024-02-05 47.5
2024-04-08 56.7 2024-02-02 47.5
2024-04-05 55.8 2024-02-01 48.3
2024-04-04 56.7 2024-01-31 48.3
2024-04-03 57.5 2024-01-30 49.2
2024-04-02 55.8 2024-01-29 49.2
2024-04-01 55.8 2024-01-26 50.0
2024-03-29 55.0 2024-01-25 48.3
2024-03-27 53.3 2024-01-24 48.3
2024-03-26 52.5 2024-01-23 46.7
2024-03-25 52.5 2024-01-22 45.0
2024-03-22 51.7 2024-01-19 45.0
2024-03-21 52.5 2024-01-18 43.3
2024-03-20 52.5 2024-01-17 45.8
2024-03-19 53.3 2024-01-16 47.5
2024-03-18 55.0 2024-01-15 48.3
2024-03-15 55.8 2024-01-12 49.2
2024-03-14 55.0 2024-01-11 48.3
2024-03-13 55.8 2024-01-10 49.2
2024-03-12 53.3 2024-01-09 48.3
2024-03-11 51.7 2024-01-08 50.8
2024-03-08 51.7 2024-01-05 50.8
2024-03-07 50.8 2024-01-04 53.3
2024-03-06 50.0 2024-01-03 53.3
2024-03-05 49.2 2024-01-02 52.5
2024-03-04 50.0 2024-01-01 50.0
2024-03-01 49.2 2023-12-29 50.0
2024-02-29 49.2 2023-12-28 49.2
2024-02-28 50.0 2023-12-27 49.2
2024-02-27 49.2 2023-12-26 49.2
2024-02-26 48.3 2023-12-22 49.2
2024-02-23 48.3 2023-12-21 49.2
2024-02-22 47.5 2023-12-20 48.3
2024-02-21 47.5 2023-12-19 50.0
2024-02-20 47.5 2023-12-18 49.2
2024-02-19 47.5 2023-12-15 49.2
2024-02-16 47.5 2023-12-14 49.2

Sunzen Biotech Bhd (XKLS:0148) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment.